Phospholamban gene dosage effects in the mammalian heart
about
Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studiesModulation of cardiac contractility by the phospholamban/SERCA2a regulatomePhospholamban: a major determinant of the cardiac force-frequency relationshipThe human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPaseMolecular regulation of phospholamban function and gene expression.Role of AMPK α in skeletal muscle glycometabolism regulation and adaptation in relation to sepsisAtrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling.Gene Expression Analyses during Spontaneous Reversal of Cardiomyopathy in Mice with Repressed Nuclear CUG-BP, Elav-Like Family (CELF) Activity in Heart Muscle.Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A.Tropomyosin dephosphorylation results in compensated cardiac hypertrophyPhospholamban overexpression in transgenic rabbitsCalcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes.Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transportThe role of SERCA2a/PLN complex, Ca(2+) homeostasis, and anti-apoptotic proteins in determining cell fate.A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids.Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury.Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart.The role of CaMKII regulation of phospholamban activity in heart disease.Phospholamban and cardiac function: a comparative perspective in vertebrates.SERCA2a: a prime target for modulation of cardiac contractility during heart failure.Posttranslational modifications of calcium/calmodulin-dependent protein kinase IIδ and its downstream signaling in human failing hearts.Transgenic approaches to define the functional role of dual site phospholamban phosphorylation.A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists.Two-pore Channels (TPC2s) and Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) at Lysosomal-Sarcoplasmic Reticular Junctions Contribute to Acute and Chronic β-Adrenoceptor Signaling in the Heart.Reduced sarcoplasmic reticulum Ca2+ -ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium.Expression of calcium regulatory proteins in short-term hibernation and stunning in the in situ porcine heart.The impact of doxorubicin and dexrazoxane injection of prepubertal female rats on pregnancy outcome and cardiac function postpartum.
P2860
Q21143760-9096C53E-AFC8-438F-9AE7-EC7A1872C82CQ24337593-79BD4C91-ACEB-46E4-AAE7-4EFC6D2AD5ACQ28587928-FDD262BA-C233-48DD-89BD-DC4D9D9B7FA6Q30516388-3460FB1C-9857-430F-BD7E-D7B6B4CC69D2Q33798507-1CCB7E51-078D-44F7-A45A-54F0E5A4E935Q33908646-07153FD3-F364-46F2-A401-2B169B61872EQ34184625-BF7BFE0D-B4D4-483F-9935-40E484D4F9E2Q35498022-A341C0E2-C816-4D65-AD4D-FBB4742025EEQ36137348-6E5C74B2-B9C9-4031-9D97-9902DBA4771AQ36492849-FD81A3A6-0E50-4B5E-B57D-AB4CB082A2EBQ36628719-C1B0AFC3-8738-413D-932A-F66A14901ABDQ36881477-3D4D5BF8-A0B3-4020-B315-06F339040752Q37138913-558C727E-622E-4648-853B-708BC678A23CQ37139450-E0FD8ECD-27F1-4B9B-B0DD-7AAA877EF605Q37357796-6FFB943E-D2EC-4F1B-8F92-5BD1C6DFC0E6Q37364808-901790A5-2549-416B-B4DF-FD7397272872Q37478226-CCE2D9D5-5D9D-41AA-A20E-3C7D575AC8EDQ37555074-BB7A3043-50FE-47C2-B61E-92872769C385Q37998559-9484E503-DB34-4030-8037-52610520C05FQ38109648-BA9A5C8E-8B00-43B5-9806-8B6E83EAE480Q41549255-F4B42217-92E2-4050-B97B-85C65E42F784Q42450966-9A1325C6-93C4-46FB-8057-E9318BB222D0Q42493338-F198D968-26B1-4D00-97AC-D7C948DB9508Q43099248-850F21A4-12B3-4B08-8B08-A69E7AF4C669Q46827526-2BF1BE88-1C7D-4E5B-BBF4-F80821C3001EQ47864011-3BC81821-E94F-4A49-823C-4F0E910B5984Q51294069-D9872151-2CC5-4BFE-A19A-B8C873336322
P2860
Phospholamban gene dosage effects in the mammalian heart
description
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1996
@ast
im Mai 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/05/01)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/05/01)
@nl
наукова стаття, опублікована в травні 1996
@uk
научни чланак (објављен 1996/05/01)
@sr
name
Phospholamban gene dosage effects in the mammalian heart
@ast
Phospholamban gene dosage effects in the mammalian heart
@en
Phospholamban gene dosage effects in the mammalian heart
@nl
type
label
Phospholamban gene dosage effects in the mammalian heart
@ast
Phospholamban gene dosage effects in the mammalian heart
@en
Phospholamban gene dosage effects in the mammalian heart
@nl
prefLabel
Phospholamban gene dosage effects in the mammalian heart
@ast
Phospholamban gene dosage effects in the mammalian heart
@en
Phospholamban gene dosage effects in the mammalian heart
@nl
P2093
P356
P1433
P1476
Phospholamban gene dosage effects in the mammalian heart
@en
P2093
B. M. Wolska
D. G. Ferguson
E. G. Kranias
I. L. Grupp
J. M. Harrer
J. P. Slack
K. Haghighi
R. J. Solaro
T. Doetschman
P304
P356
10.1161/01.RES.78.5.839
P577
1996-05-01T00:00:00Z